Acute respiratory distress syndrome (ARDS) is characterized by refractory hypoxemia caused by accumulation of pulmonary fluid with a high mortality rate, but the underlying mechanism is not yet fully understood, causing absent specific therapeutic drugs to treat with ARDS . In recent years, more and more studies have applied proteomics to ARDS . Non-targeted studies of proteomics in ARDS are just beginning and have the potential to identify novel drug targets and key pathways in this disease . This paper will provide a brief review of the recent advances in the application of non-targeted proteomics to ARDS.
Index: ARDS, Clinical applications, Non-targeted proteomics, Study designs